Search Department of Consumer Protection Filtered Topic Search

Suspicious Order Monitoring


Section 3 Public Act 18-16 required that each manufacturer or wholesaler of drugs shall operate a system to identify suspicious orders of controlled substances and shall immediately inform the Director of Drug Control Division of suspicious orders.  Suspicious orders include, but are not limited to, orders of unusual size, orders deviating substantially from a normal pattern and orders of unusual frequency.  Each registered manufacturer or wholesaler of drugs shall also send the Drug Control Division a copy of any suspicious activity reporting submitted to the federal Drug Enforcement Administration pursuant to 21 CFR 1301.74.

Frequently Asked Questions

1.  How do I report a suspicious order to the Director Drug Control Division?

Reports will be accepted via email to or via fax to (860) 706-1207.

2. What information should be contained in the suspicious order report?

Include the report that you would normally send to the Drug Enforcement Administration (DEA) plus the Connecticut license number of the facility.